Skip to main content
Livermore
Livermore
ZHEN

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Perspective Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of CATX: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders52104+52
Shares36.6M247.7M+211.1M (+576.9%)
Value$14.7M$294.6M+$279.9M (+1,904.0%)

New holders (56)

Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to CATX in Q1 2024
InstitutionSharesValue% of portfolio
Deerfield Management Company, L.P. (Series C)28,177,636$33.5M0.58%
Commodore Capital LP21,052,631$25.1M1.68%
Marshall Wace, LLP18,971,733$22.6M0.04%
Octagon Capital Advisors LP14,718,422$17.5M2.13%
Point72 Asset Management, L.P.13,453,255$16.0M0.05%
Janus Henderson Group PLC13,089,476$15.5M0.01%
Citadel Advisors LLC12,267,432$14.6M0.01%
Hills Bank & Trust Co10,358,305$12.3M1.05%
Laurion Capital Management LP8,918,918$10.6M0.30%
Silverarc Capital Management, LLC8,108,108$9.65M2.71%
OrbiMed Advisors LLC6,505,800$7.74M0.15%
Millennium Management LLC5,794,725$6.90M0.01%
Affinity Asset Advisors, LLC5,100,000$6.07M0.99%
DAFNA Capital Management LLC3,103,644$3.69M0.84%
ExodusPoint Capital Management, LP2,888,937$3.44M0.04%
Schonfeld Strategic Advisors LLC2,830,400$3.37M0.03%
Goldman Sachs Group Inc1,996,511$2.38M0.00%
AlphaCentric Advisors LLC1,756,756$2.09M1.26%
Citigroup Inc1,035,339$1.23M0.00%
Hudson Bay Capital Management LP850,000$1.01M0.01%
EAM Investors, LLC843,161$1.00M0.16%
Tri Locum Partners LP780,303$928.6K0.32%
Mayo Clinic724,641$862.3K14.03%
Atom Investors LP551,279$656.0K0.08%
Altium Capital Management LP535,657$637.4K0.28%
Susquehanna International Group, LLP535,293$637.0K0.00%
Cubist Systematic Strategies, LLC527,470$627.7K0.01%
Sofinnova Investments, Inc.430,105$511.8K0.03%
AMG National Trust Bank373,300$444.2K0.01%
Qube Research & Technologies Ltd246,244$293.0K0.00%
Virtu Financial LLC115,762$138.0K0.01%
LMR Partners LLP115,488$137.4K0.00%
Balyasny Asset Management LLC111,723$132.9K0.00%
Polymer Capital Management (HK) LTD103,773$123.5K0.03%
Vontobel Holding Ltd.80,000$95.2K0.00%
CTC Alternative Strategies, Ltd.69,900$83.2K0.05%
Barclays PLC69,006$82.1K0.00%
Marathon Trading Investment Management LLC47,000$55.9K0.02%
Omers Administration Corp45,200$53.8K0.00%
Jefferies Financial Group Inc.43,500$51.8K0.00%
Brevan Howard Capital Management LP38,994$46.4K0.00%
Sykon Capital LLC36,215$43.1K0.02%
Simplicity Wealth,LLC33,570$39.9K0.00%
Bleakley Financial Group, LLC33,570$39.9K0.00%
Squarepoint Ops LLC28,990$34.5K0.00%
TradeLink Capital LLC27,000$32.0K0.48%
ZWJ Investment Counsel Inc22,000$26.2K0.00%
Prudential Financial Inc14,400$17.1K0.00%
Twinbeech Capital LP14,377$17.1K0.00%
Two Sigma Securities, LLC14,152$16.8K0.00%
Cetera Investment Advisers12,500$14.9K0.00%
Old Point Trust & Financial Services N A2,500$2.98K0.00%
Scarborough Advisors, LLC109$1300.00%
Macquarie Group Ltd13,988$170.00%
Mercer Global Advisors Inc4––
Moneta Group Investment Advisors LLC23,708––

Sold out (4)

Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of CATX in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Perkins Capital Management Inc700,000$281.0K
TMD Wealth Management, LLC20,000$8.04K
AE Wealth Management LLC10,850$6.79K
Advisory Services Network, LLC1,000$402